Pharma channel feed – Endpoints News

Pharma channel feed

What’s driving the rapid growth of the top 20 biopharma companies in the world?

8 years ago

Alexion bags a blockbuster new approval for its cash cow Soliris. Now what?

8 years ago

AbbVie antes up $225M in cash to buy into the Alzheimer's platform at Alector

8 years ago

FDA adds fresh ‘breakthrough’ for Novartis' cancer combo Tafinlar and Mekinist

8 years ago

GSK grabs FDA OK for new shingles vaccine, which will now tackle a key Merck franchise

8 years ago

Eyeing an IPO, ADC Therapeutics fuels pivotal cancer trials with a $200M mega-round backed by AstraZeneca

8 years ago

Buzz: Will Brent Saunders split up Allergan if he loses the Restasis patent fight?

8 years ago

Seattle's Universal Cells brings Astellas into its fold of off-the-shelf cell therapy partners

8 years ago

FDA releases flurry of new, revised drug-specific guidance documents

8 years ago

Celgene’s $710M deal on mongersen implodes as Phase III Crohn's study flops

8 years ago

Unicorn hunter Vivek Ramaswamy has cooked up a new deal with AstraZeneca. But what is it?

8 years ago

After some painful R&D setbacks, J&J partners with Arcturus on a shot at a hep B cure  — shares rocket up

8 years ago

FDA follows through with a groundbreaking OK for Yescarta, Gilead's new CAR-T breakthrough

8 years ago

FDA experts shrug off retinopathy concerns, offer (near) unanimous thumbs up for Novo Nordisk's semaglutide

8 years ago

Eli Lilly is making a $1.8B leap into the mRNA field, targeting next-gen cancer vaccines

8 years ago

Many questions, few answers in Senate hearing on opaque US drug pricing system

8 years ago

After jumping ship at Eli Lilly, Politico reports Alex Azar may soon land top HHS job

8 years ago

Cascade of costs could push CAR-T therapy to $1.5M per patient

8 years ago

Allergan slammed as federal judge invalidates Restasis patents, slaps Mohawk deal

8 years ago

FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key

8 years ago

EMA counters the academics who criticized the cancer drug approval process

8 years ago

Roche ties a $387M knot with Warp Drive Bio in collaboration spotlighting new classes of antibiotics

8 years ago

FDA experts give a thumbs-up to Aerie Pharma’s glaucoma drug

8 years ago

That $1.25B Bristol-Myers IDO1 drug? Incyte claims a former staffer stole it

8 years ago

First page Previous page 311 312 313314315 316 317 Next page Last page